CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 4 Grant or award President, U.S. Market acquired 8,664 shares (grant or award)
- 4 Grant or award EVP & CFO acquired 23,432 shares (grant or award)
- 4 Grant or award Executive VP & President, MRL acquired 32,621 shares (grant or award)
- 4 Grant or award Chief Comm. & Public Afrs Ofcr acquired 9,446 shares (grant or award)
- 4 Grant or award EVP&Pres, Merck Animal Heallth acquired 25,438 shares (grant or award)
- 4 Grant or award Chairman, CEO & President acquired 95,275 shares (grant or award)
- 4 Grant or award Exe V-P & Pres. MMD acquired 28,136 shares (grant or award)
- 4 Grant or award Chief Marketing Officer acquired 28,158 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Bylaws or fiscal year change
- SC 13G/A Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 25-NSE Other Notification of Removal from Listing
- 8-K Event Results of operations
Page 13 of 152 · 3,038 filings